Plasma α‐synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson’s disease

The use of a diagnostic panel comprising multiple biomarkers has the potential to accurately diagnose Parkinson’s disease (PD). However, a panel consisting solely of plasma biomarkers to diagnose PD is not available. This study aimed to examine the diagnostic ability of plasma biomarker panels for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jingru, Pan, Chenxi, Wang, Yajie, Xue, Chen, Lin, Huixia, Xu, Jianxia, Wang, Hui, Zhang, Wenbin, Xu, Pingyi, Chen, Yong, Liu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314946/
https://www.ncbi.nlm.nih.gov/pubmed/35234288
http://dx.doi.org/10.1111/jnc.15601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314946/
https://www.ncbi.nlm.nih.gov/pubmed/35234288
http://dx.doi.org/10.1111/jnc.15601

Ejemplares similares